| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8823783 | Journal of Vascular and Interventional Radiology | 2018 | 7 Pages |
Abstract
The prognosis of patients with metastases from CRC is impacted by a complex set of clinical parameters. This analysis of pretreatment factors identified lower AST, lower CEA, lower NLR, and lower tumor burden (intra- or extrahepatic) to be independently associated with higher survival after hepatic RE. Optimal selection of patients with CRC liver metastases may improve survival rates after administration of yttrium-90.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Radiology and Imaging
Authors
Ashley A. MD, PhD, Bin MD, Neil B. MD, MS, John L. MD, Fady MD, Shou-En PhD, Gretchen M. MD, Darren MD, PhD, Jonathan BS, Darryl A. MD, Ben MD, Jeffrey R. MD, Salma K. MD, Parag J. MD,